Coave Therapeutics Announces Formation of Scientific Advisor

/PRNewswire/ -- Coave Therapeutics ('Coave'), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central...

Related Keywords

Germany , Italy , Alabama , United States , Paris , France General , France , Clerval , Franche Comtér , Eleanor Perkin , Olivier Danos , Mark Richardson , Sylvie Berrebi , Charlesa Pappas , Erwan Bezard , David Standaert , Anthony Schapira , Stephane Palfi , Thomas Gasser , Thomas Blaettler , Johnn Whitaker , Lamya Shihabuddin , Andrea Ballabio , Linkedin , University Of Bordeaux , Institute Of Neurodegenerative Diseases , Paris University , Harvard Medical School , Head Of Department Clinical Neuroscience , Ventures Company , Telethon Institute Of Genetics , University Of Tuebingen , Institute Of Neurology , Seroba Life Sciences , Central Nervous System , Scientific Advisory Board , Adeno Associated Virus , Chief Medical Officer , Telethon Institute , Research Director , Neurodegenerative Diseases , Chief Scientific Officer , Neurosurgery Department , Henri Mondor Medical Center , Associate Professor , Clinical Neuroscience , Neurology Clinic , Ligand Conjugate , Open Innovation , Omnes Capital , V Bio Ventures , Kurma Partners , Sham Innovation Sant , Mark Swallow , Coave Therapeutics ,